BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1487489)

  • 1. Dolichol delays G1-arrest for one cell cycle in human fibroblasts subjected to depletion of serum or mevalonate.
    Larsson O; Wejde J
    J Cell Sci; 1992 Dec; 103 ( Pt 4)():1065-72. PubMed ID: 1487489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of virus-transformation and growth factor stimulation on isoprene biosynthesis in human fibroblasts: a correlation to cell growth.
    Larsson O
    Cancer Biochem Biophys; 1995 Jan; 14(4):243-56. PubMed ID: 7767898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abolition of mevinolin-induced growth inhibition in human fibroblasts following transformation by simian virus 40.
    Larsson O; Barrios C; Latham C; Ruiz J; Zetterberg A; Zickert P; Wejde J
    Cancer Res; 1989 Oct; 49(20):5605-10. PubMed ID: 2551491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isoprenoids and astroglial cell cycling: diminished mevalonate availability and inhibition of dolichol-linked glycoprotein synthesis arrest cycling through distinct mechanisms.
    Langan TJ; Slater MC
    J Cell Physiol; 1991 Nov; 149(2):284-92. PubMed ID: 1748720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of 25-hydroxycholesterol, cholesterol, and isoprenoid derivatives on the G1 progression in Swiss 3T3 cells.
    Larsson O; Zetterberg A
    J Cell Physiol; 1986 Oct; 129(1):94-102. PubMed ID: 3760035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isoprenoid regulation of cell growth: identification of mevalonate-labelled compounds inducing DNA synthesis in human breast cancer cells depleted of serum and mevalonate.
    Wejde J; Carlberg M; Hjertman M; Larsson O
    J Cell Physiol; 1993 Jun; 155(3):539-48. PubMed ID: 8491791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Requirement for mevalonate in cycling cells: quantitative and temporal aspects.
    Doyle JW; Kandutsch AA
    J Cell Physiol; 1988 Oct; 137(1):133-40. PubMed ID: 3170653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mevalonic acid products as mediators of cell proliferation in simian virus 40-transformed 3T3 cells.
    Larsson O; Johansson BM
    Cancer Res; 1987 Sep; 47(18):4825-9. PubMed ID: 3040232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of biosynthesis of cholesterol and isoprenoid derivatives in regulation of G1 progression and cell proliferation of 3T6 cells.
    Larsson O
    J Cell Physiol; 1987 Oct; 133(1):163-8. PubMed ID: 3667703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lovastatin-mediated G1 arrest is through inhibition of the proteasome, independent of hydroxymethyl glutaryl-CoA reductase.
    Rao S; Porter DC; Chen X; Herliczek T; Lowe M; Keyomarsi K
    Proc Natl Acad Sci U S A; 1999 Jul; 96(14):7797-802. PubMed ID: 10393901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell cycle regulation of human diploid fibroblasts: possible mechanisms of platelet-derived growth factor.
    Larsson O; Latham C; Zickert P; Zetterberg A
    J Cell Physiol; 1989 Jun; 139(3):477-83. PubMed ID: 2738097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase synthesis in Syrian hamster C100 cells by mevinolin, 25-hydroxycholesterol, and mevalonate: the role of posttranscriptional control.
    Peffley DM
    Somat Cell Mol Genet; 1992 Jan; 18(1):19-32. PubMed ID: 1546367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between mevalonate and mitogenesis in human fibroblasts stimulated with platelet-derived growth factor.
    Fairbanks KP; Witte LD; Goodman DS
    J Biol Chem; 1984 Feb; 259(3):1546-51. PubMed ID: 6693424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation of neuroblastoma cells induced by an inhibitor of mevalonate synthesis: relation of neurite outgrowth and acetylcholinesterase activity to changes in cell proliferation and blocked isoprenoid synthesis.
    Maltese WA; Sheridan KM
    J Cell Physiol; 1985 Dec; 125(3):540-58. PubMed ID: 3851809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Requirement for mevalonate in the control of proliferation of human breast cancer cells.
    Wejde J; Blegen H; Larsson O
    Anticancer Res; 1992; 12(2):317-24. PubMed ID: 1580550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mevalonate reverses the developmental arrest of preimplantation mouse embryos by Compactin, an inhibitor of HMG Co A reductase.
    Surani MA; Kimber SJ; Osborn JC
    J Embryol Exp Morphol; 1983 Jun; 75():205-23. PubMed ID: 6886611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arrest of 3T3 cells in G1 phase by low density lipoprotein.
    Takii Y; Higashi M; Masamune Y; Ito F
    Cell Struct Funct; 1983 Sep; 8(3):199-209. PubMed ID: 6671216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mevalonate prevents lovastatin-induced apoptosis in medulloblastoma cell lines.
    Wang W; Macaulay RJ
    Can J Neurol Sci; 1999 Nov; 26(4):305-10. PubMed ID: 10563217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell cycle-specific growth inhibition of human breast cancer cells induced by metabolic inhibitors.
    Larsson O
    Glycobiology; 1993 Oct; 3(5):475-9. PubMed ID: 8286860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plant-derived monoterpenes suppress hamster kidney cell 3-hydroxy-3-methylglutaryl coenzyme a reductase synthesis at the post-transcriptional level.
    Peffley DM; Gayen AK
    J Nutr; 2003 Jan; 133(1):38-44. PubMed ID: 12514264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.